Institutional Ownership
Arcutis Biotherapeutics Inc
CUSIP 03969K108COMARQTQ1 2026
13D / 13G Filings
59
Schedule 13D/13G on record
Beneficial Filers
16
Distinct reporting persons
Largest Stake
27.7%
Max % of class reported
Institutional Holders
260
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
59 filings · latest Feb 13, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 13, 2026 | Prudential Financial Inc | 13G/A | 5.7% | 7.08M | SEC |
| 2 | Feb 13, 2026 | Rubric Capital Management LP | 13G/A | 6.8% | 8.27M | SEC |
| 3 | Jan 30, 2026 | Jennison Associates LLC | 13G/A | 5.5% | 6.76M | SEC |
| 4 | Oct 6, 2025 | Jennison Associates LLC | 13G/A | 10.2% | 12.25M | SEC |
| 5 | Aug 20, 2025 | Frazier Life Sciences Viii, L.P. | 13D/A | 7.5% | — | SEC |
| 6 | Aug 14, 2025 | Polar Capital Holdings PLC | 13G/A | 4.2% | 5.01M | SEC |
| 7 | May 15, 2025 | Polar Capital Holdings PLC | 13G/A | 5.7% | 6.71M | SEC |
| 8 | May 15, 2025 | Prudential Financial Inc | 13G/A | 10.1% | 11.95M | SEC |
| 9 | May 8, 2025 | Jennison Associates LLC | 13G/A | 9.6% | 177.68M | SEC |
| 10 | Nov 14, 2024 | Point72 Asset Management, L.P. | 13G/A | 0.2% | 247.1K | SEC |
49 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Arcutis Biotherapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Suvretta Capital Management, LLC | 12.33M | $290.42M |
| 2 | Frazier Life Sciences Management, L.P. | 9.87M | $232.64M |
| 3 | Blackrock, Inc. | 9.20M | $216.76M |
| 4 | Rubric Capital Management LP | 8.27M | $194.88M |
| 5 | State Street Corp | 6.30M | $148.34M |
| 6 | Polar Capital Holdings PLC | 5.67M | $133.51M |
| 7 | Jennison Associates LLC | 4.98M | $117.35M |
| 8 | Gilder Gagnon Howe & Co LLC | 4.30M | $101.40M |
| 9 | Morgan Stanley | 4.22M | $99.40M |
| 10 | Ubs Group AG | 3.33M | $78.44M |